Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases

BACKGROUND: Radioactive iodine 131 ((131)I) therapy has long been used in the treatment of differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications secondary to (131)I therapy are well documented, there is little in the literature addressing nasolacrimal duct obstruc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Main Authors: Al-Qahtani, Khalid Hussain, Al Asiri, Mushabbab, Tunio, Mutahir A, Aljohani, Naji J, Bayoumi, Yasser, Munir, Iqbal, AlAyoubi, Ayman
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266423/
https://ncbi.nlm.nih.gov/pubmed/25525325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S71708
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados